Oxcarbazepine Suspension
Product Images NDC 85742-007

8 FDA label images from Kanchan Healthcare Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 85742-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kanchan Healthcare Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine-7 (Oxcarbazepine 7)

Oxcarbazepine-7 (Oxcarbazepine 7)
Chemical structure of oxcarbazepine, showing its molecular framework with a ketone group and an amide side group attached to a dibenzazepine ring system.*
FDA Label Image

Oxcarbazepine-9 (Oxcarb 9)

Oxcarbazepine-9 (Oxcarb 9)
A Kaplan-Meier survival plot showing exit rates over time from day 2 to day 11, comparing treatment groups Oxcarbazepine and Placebo. The graph includes a log-rank test p-value of 0.0001 indicating statistical comparison between the groups.*
FDA Label Image

Oxcarb-10 (Oxcarb 10)

Oxcarb-10 (Oxcarb 10)
A Kaplan-Meier survival curve showing seizure rates over days from first dose to first seizure, comparing treatment groups of Oxcarbazepine suspension and placebo. The y-axis represents seizure rate, and the x-axis represents days. The graph includes a log-rank test p-value of 0.046 indicating statistical comparison between groups.*
FDA Label Image

Oxcarb-11 (Oxcarb 11)

Oxcarb-11 (Oxcarb 11)
A survival curve chart showing the time to exit over days for two treatment groups labeled HIGH and LOW. The y-axis represents exit rate from 0 to 1.0, and the x-axis represents time to exit in days, ranging from 0 to 130. The chart includes a p-value of 0.0001 from a log-rank test comparing the two groups.*
FDA Label Image

Oxcar-12 (Oxcar 12)

Oxcar-12 (Oxcar 12)
A Kaplan-Meier survival plot comparing time to exit (days) between two treatment groups labeled HIGH and LOW. The y-axis represents the exit rate from 0.0 to 1.0, and the x-axis represents time to exit in days, up to 130. The plot includes a log-rank test p-value of 0.0001 indicating statistical comparison between groups.*
FDA Label Image

Oxcarbazepine-25 (Oxcarbazepine 25)

Oxcarbazepine-25 (Oxcarbazepine 25)
Label for Oxcarbazepine Oral Suspension USP 300 mg/5 mL, a 250 mL oral suspension. The label includes the NDC 85742-007-06 and is manufactured by Medley Pharmaceuticals Ltd and Kanchan Healthcare Inc. It instructs to shake well before use, contains dosage details, storage instructions, and pharmacist dispensing guidance.*
FDA Label Image

Oxcar-26 (Oxcar 26)

Oxcar-26 (Oxcar 26)
Label for Oxcarbazepine Oral Suspension USP, 300 mg/5 mL, 250 mL bottle by Kanchan Healthcare Inc. The label includes instructions to shake well before use, contains 300 mg oxcarbazepine per 5 mL, and storage information. Manufactured by Medley Pharmaceuticals Ltd, India, and distributed by Kanchan Healthcare Inc, USA.*
FDA Label Image

Oxcar-ifu (Oxcar Ifu)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.